Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann T Moriarty

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Diagnostic Cytopathology|July 20, 2007
A rock and a hard place: HPV testing and financial gainAnn T Moriarty
Cancer Cytopathology|March 3, 2011
Cytology workload calculation-has anything really changed?Ann T Moriarty
Cancer Cytopathology|June 16, 2012
p16INK4a-is the future of cervical cancer screening rosy?Ann T Moriarty
Diagnostic Cytopathology|November 26, 2008
A threat to cervical cancer screeningAnn T Moriarty, Daniel Kurtycz
Diagnostic Cytopathology|April 3, 2003
Those gland problems in cervical cytology: faith or fact? Observations from the Bethesda 2001 terminology conferenceAnn T Moriarty, Dave Wilbur
Diagnostic Cytopathology|June 27, 2003
The four R's: reactive/repair, reporting, and regulationsAnn T Moriarty, Nancy A Young
Diagnostic Cytopathology|March 18, 2006
Does a license ensure or censure?Ann T Moriarty, Barbara Dubray-Benstein, Jean Taylor
Archives of Pathology & Laboratory Medicine|August 6, 2009
Commentary on statement on human papillomavirus test utilizationJohn Thomas Cox, Ann T Moriarty, Philip E Castle
Diagnostic Cytopathology|May 22, 2009
Commentary on: Statement on HPV DNA test utilizationJ Thomas Cox, Ann T Moriarty, Philip E Castle
Journal of Lower Genital Tract Disease|June 25, 2009
Commentary on: Statement on HPV DNA test utilizationJohn Thomas Cox, Ann T Moriarty, Philip E Castle
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Diagnostic Cytopathology|July 20, 2007
A rock and a hard place: HPV testing and financial gainAnn T Moriarty
Cancer Cytopathology|March 3, 2011
Cytology workload calculation-has anything really changed?Ann T Moriarty
Cancer Cytopathology|June 16, 2012
p16INK4a-is the future of cervical cancer screening rosy?Ann T Moriarty
Diagnostic Cytopathology|November 26, 2008
A threat to cervical cancer screeningAnn T Moriarty, Daniel Kurtycz
Diagnostic Cytopathology|April 3, 2003
Those gland problems in cervical cytology: faith or fact? Observations from the Bethesda 2001 terminology conferenceAnn T Moriarty, Dave Wilbur
Diagnostic Cytopathology|June 27, 2003
The four R's: reactive/repair, reporting, and regulationsAnn T Moriarty, Nancy A Young
Diagnostic Cytopathology|March 18, 2006
Does a license ensure or censure?Ann T Moriarty, Barbara Dubray-Benstein, Jean Taylor
Archives of Pathology & Laboratory Medicine|August 6, 2009
Commentary on statement on human papillomavirus test utilizationJohn Thomas Cox, Ann T Moriarty, Philip E Castle
Diagnostic Cytopathology|May 22, 2009
Commentary on: Statement on HPV DNA test utilizationJ Thomas Cox, Ann T Moriarty, Philip E Castle
Journal of Lower Genital Tract Disease|June 25, 2009
Commentary on: Statement on HPV DNA test utilizationJohn Thomas Cox, Ann T Moriarty, Philip E Castle
Pageof 6